The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 45, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include the above mentioned amino acid sequence with substitution deletion, or addition of one, two, or several amino acids sequences. The invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for diagnosing or treating cancer.本發明提供來自序列辨識號：45之經分離胜肽或其片段，其與HLA抗原結合並誘導細胞毒殺性T淋巴球。胜肽可包括具有一、二或數個胺基酸序列之取代、刪除的上述胜肽。本發明也提供包括這些胜肽的藥學組合物。可使用本發明之胜肽來診斷或治療癌症。
